Cowen reissued their in-line rating on shares of R1 RCM (NASDAQ:RCM) in a research report sent to investors on Monday morning, The Fly reports. The brokerage currently has a $10.00 price objective on the financial services provider’s stock, up from their previous price objective of $5.00.
A number of other analysts also recently weighed in on RCM. BidaskClub raised shares of R1 RCM from a buy rating to a strong-buy rating in a research report on Wednesday, December 27th. Zacks Investment Research downgraded shares of R1 RCM from a hold rating to a sell rating in a research report on Wednesday, January 17th. Finally, Robert W. Baird reissued a hold rating and set a $7.00 target price on shares of R1 RCM in a research report on Monday, February 26th.
Shares of R1 RCM (NASDAQ:RCM) opened at $7.16 on Monday. R1 RCM has a 52-week low of $2.40 and a 52-week high of $7.17.
Several institutional investors have recently bought and sold shares of RCM. Citadel Advisors LLC bought a new position in shares of R1 RCM during the 4th quarter worth approximately $112,000. Virtu Financial LLC bought a new position in shares of R1 RCM during the 4th quarter worth approximately $166,000. Voya Investment Management LLC bought a new position in shares of R1 RCM during the 2nd quarter worth approximately $170,000. Nationwide Fund Advisors bought a new position in shares of R1 RCM during the 2nd quarter worth approximately $215,000. Finally, Two Sigma Advisers LP boosted its holdings in shares of R1 RCM by 436.4% during the 4th quarter. Two Sigma Advisers LP now owns 59,000 shares of the financial services provider’s stock worth $260,000 after buying an additional 48,000 shares in the last quarter. Hedge funds and other institutional investors own 48.81% of the company’s stock.
WARNING: This piece of content was reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3259026/r1-rcm-rcm-earns-in-line-rating-from-cowen.html.
R1 RCM Company Profile
R1 RCM Inc is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship.
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.